Hazelden Betty Ford Foundation
322 8th Avenue 12th Floor, New York City, New York, 10001
Hazelden helps restore hope, healing, and health to people affected by addiction to alcohol and other drugs. All who seek recovery will find it, and the stigma of addiction will be overcome. Treat the whole person as well as the illness. Treat every person with dignity and respect. Continue a commitment to the Twelve Step fellowship. Be of service. Remain open to innovation.
Facility Highlights
- Located in the heart of Manhattan with easy access to public transportation
- Use of evidence-based treatment methods
- Access to recovery resources to support patients after discharge
Specialization
Aftercare Support
Addiction recovery does not end with discharge after completing a rehab program. Facilities that offer aftercare planning and/or support work with patients to ensure sustainable recovery by helping to plan and make arrangements for transitional or sober living, help with housing, vocational counseling, etc.Individual Therapy
This term describes one-on-one therapy, in which a patient and trained counselor, social worker, psychologist or psychiatrist meets privately with a patient to discuss challenges related to lifestyle, work, family and romantic relationships that may have contributed to the development of an addiction.
Facility Settings
- Average Location/Amenities
Meet the Staff
Kimberly HoppesClinical DirectorKimberly Hoppes, PsyD, received her Doctorate in Clinical Psychology from the Graduate School of Applied and Professional Psychology at Rutgers University in 1988. Prior to joining Hazelden as the clinical director, she was a clinical assistant professor in Psychiatry at Mount Sinai Medical Center and the clinical director of the Alcohol and Other Drugs (AOD) Treatment Program. In response to the specific challenges of dually-diagnosed patients, she has specialized in applying a mindfulness-based treatment protocol in her clinical work with addicted clients. This work has been published in an international neuropsychiatric journal and was presented at the Society for the Study of Addiction Annual Symposium in the United Kingdom.
Financial Details
- Less than 60%